StockNews.com Initiates Coverage on Heska (NASDAQ:HSKA)

Posted by on Jun 8th, 2023

Investment analysts at StockNews.com initiated coverage on shares of Heska (NASDAQ:HSKA – Get Rating) in a report issued on Thursday. The firm set a “hold” rating on the medical research company’s stock.

Other equities research analysts have also recently issued reports about the company. Alliance Global Partners cut Heska from a “buy” rating to a “neutral” rating in a research report on Monday, April 3rd. Piper Sandler dropped their price target on shares of Heska from $165.00 to $150.00 in a report on Thursday, March 2nd. Finally, Morgan Stanley boosted their price objective on shares of Heska from $58.00 to $120.00 and gave the company an “equal weight” rating in a report on Tuesday, April 4th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $137.25.

Heska Stock Performance

HSKA stock opened at $119.87 on Thursday. The stock’s 50 day simple moving average is $116.55 and its 200 day simple moving average is $90.62. The company has a current ratio of 5.64, a quick ratio of 4.12 and a debt-to-equity ratio of 0.23. Heska has a 12-month low of $57.83 and a 12-month high of $119.95. The stock has a market capitalization of $1.31 billion, a PE ratio of -62.11 and a beta of 1.58.

Hedge Funds Weigh In On Heska

Institutional investors and hedge funds have recently made changes to their positions in the business. Fred Alger Management LLC boosted its stake in shares of Heska by 54.3% during the 1st quarter. Fred Alger Management LLC now owns 828,868 shares of the medical research company’s stock worth $80,914,000 after acquiring an additional 291,763 shares during the last quarter. Federated Hermes Inc. grew its holdings in Heska by 5,737.5% during the third quarter. Federated Hermes Inc. now owns 114,124 shares of the medical research company’s stock valued at $8,322,000 after purchasing an additional 112,169 shares during the period. Assenagon Asset Management S.A. increased its position in Heska by 510.2% in the fourth quarter. Assenagon Asset Management S.A. now owns 127,809 shares of the medical research company’s stock worth $7,945,000 after buying an additional 106,864 shares in the last quarter. Jennison Associates LLC bought a new position in shares of Heska in the first quarter worth about $8,156,000. Finally, Palisade Capital Management LP purchased a new position in shares of Heska during the 1st quarter valued at about $7,586,000. Hedge funds and other institutional investors own 99.01% of the company’s stock.

Heska Company Profile

(Get Rating)

Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through the North America and International segments. The North America segment includes the United States, Canada, and Mexico. The International segment involves Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland.

Featured Articles

Receive News & Ratings for Heska Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska and related companies with MarketBeat.com's FREE daily email newsletter.